UPDATE: BioCryst Pharmaceuticals Posts Narrower-Than-Expected Q4 Loss

By: via Benzinga
BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX) reported a narrower-than-expected loss for the fourth quarter. The Durham, North ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.